Marker Therapeutics Competitors and Similar CompaniesClear all
ImmunoCellular Therapeutics's competitors and similar companies include Advaxis.
 ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers. | ||
Founding Date | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Calabasas, US HQ | Locations Princeton, US HQ |
Employees | Employees 357% decrease | Employees 3540% decrease |
Valuation ($) | Valuation ($) 15.9 m | Valuation ($) 2.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $13k (FY, 2023) |
Net income | Net income ($14.3m) (FY, 2017) | Net income ($48.1m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 32.5m | Total funding raised $ 50.5m |
For sources of this data, please see the company profile
View Company Profiles
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company